MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot

Canadian Journal of Cardiology

Volumn 29, Issue 12, 2013, Pages 1695-1703

  Zhang, Jin ^a   Chang, Jiao Jiao ^a   Xu, Fei ^a   Ma, Xiao Jing ^a   Wu, Yao ^a   Li, Wen Chan ^a   Wang, Hui Jun ^a   Huang, Guo Ying ^a   Ma, Duan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FALLOT TETRALOGY; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; MUSCLE RESECTION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; MICE; MICRORNAS; MODELS, GENETIC; MYOCARDIUM; MYOCYTES, CARDIAC; TETRALOGY OF FALLOT; TISSUE ARRAY ANALYSIS; UP-REGULATION; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84888296828     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.07.002     Document Type: Article

References (48)

1. Starr J.P. Tetralogy of fallot: yesterday and today. World J Surg 2010, 34:658-668.
2. Humayun K.N., Atiq M. Clinical profile and outcome of cyanotic congenital heart disease in neonates. JColl Physicians Surg Pak 2008, 18:290-293.
3. Pinsky W.W., Arciniegas E. Tetralogy of Fallot. Pediatr Clin North Am 1990, 37:179-192.
4. Di Felice V., Zummo G. Tetralogy of fallot as a model to study cardiac progenitor cell migration and differentiation during heart development. Trends Cardiovasc Med 2009, 19:130-135.
5. Yap S.C., Harris L. Sudden cardiac death in adults with congenital heart disease. Exp Rev Cardiovasc Ther 2009, 7:1605-1620.
6. Massin M.M., Malekzadeh-Milani S.G., Schifflers S., Dessy H., Verbeet T. Long-term electrocardiographic follow-up after repair of tetralogy of Fallot. Ann Noninvasive Electrocardiol 2011, 16:336-343.
7. Goldmuntz E. DiGeorge syndrome: new insights. Clin Perinatol 2005, 32:963-978. ix-x.
8. Goldmuntz E., Geiger E., Benson D.W. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 2001, 104:2565-2568.
9. Bauer R.C., Laney A.O., Smith R., et al. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat 2010, 31:594-601.
10. Greenway S.C., Pereira A.C., Lin J.C., et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nature Genet 2009, 41:931-935.
11. Tan Z.P., Huang C., Xu Z.B., Yang J.F., Yang Y.F. Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle. Clin Genet 2012, 82:466-471.
12. Pizzuti A., Sarkozy A., Newton A.L., et al. Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. Hum Mutat 2003, 22:372-377.
13. Silversides C.K., Lionel A.C., Costain G., et al. Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genet 2012, 8:e1002843.
14. Soemedi R., Topf A., Wilson I.J., et al. Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 2012, 21:1513-1520.
15. Rauch R., Hofbeck M., Zweier C., et al. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. JMed Genet 2010, 47:321-331.
16. Hu Y., Zhu X., Yang Y., et al. Incidences of micro-deletion/duplication 22q11.2 detected by multiplex ligation-dependent probe amplification in patients with congenital cardiac disease who are scheduled for cardiac surgery. Cardiol Young 2009, 19:179-184.
17. Lammer E.J., Chak J.S., Iovannisci D.M., et al. Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol 2009, 85:30-35.
18. Thai T.H., Christiansen P.A., Tsokos G.C. Is there a link between dysregulated miRNA expression and disease?. Discov Med 2010, 10:184-194.
19. Kawashima T., Shioi T. MicroRNA, emerging role as a biomarker of heart failure. Circ J 2011, 75:268-269.
20. Latronico M.V., Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009, 6:419-429.
21. Adachi T., Nakanishi M., Otsuka Y., et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010, 56:1183-1185.
22. Chinchilla A., Lozano E., Daimi H., et al. MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc Res 2011, 89:98-108.
23. Morton S.U., Scherz P.J., Cordes K.R., et al. microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci US A 2008, 105:17830-17835.
24. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997, 35:2-3.
25. Zhang J., Du Y.Y., Lin Y.F., et al. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008, 377:136-140.
26. Rodgers L.S., Schnurr D.C., Broka D., Camenisch T.D. An improved protocol for the isolation and cultivation of embryonic mouse myocytes. Cytotechnology 2009, 59:93-102.
27. Wobus A.M., Kleppisch T., Maltsev V., Hescheler J. Cardiomyocyte-like cells differentiated invitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels. InVitro Cell Dev Biol Anim 1994, 30A:425-434.
28. Takaya T., Ono K., Kawamura T., et al. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009, 73:1492-1497.
29. Care A., Catalucci D., Felicetti F., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
30. Danielson L.S., Park D.S., Rotllan N., et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J 2013, 27:1460-1467.
31. Phillips H.M., Murdoch J.N., Chaudhry B., Copp A.J., Henderson D.J. Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract. Circ Res 2005, 96:292-299.
32. Poelmann R.E., Molin D., Wisse L.J. Gittenberger-de Groot AC. Apoptosis in cardiac development. Cell Tissue Res 2000, 301:43-52.
33. Risebro C.A., Smart N., Dupays L., et al. Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart. Development 2006, 133:4595-4606.
34. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006, 126:1037-1048.
35. van der Heyden M.A., Defize L.H. Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 2003, 58:292-302.
36. Jacks T., Shih T.S., Schmitt E.M., et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994, 7:353-361.
37. Brannan C.I., Perkins A.S., Vogel K.S., et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994, 8:1019-1029.
38. Morgan S.C., Lee H.Y., Relaix F., et al. Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest. Mech Dev 2008, 125:757-767.
39. Lee J.S., Padmanabhan A., Shin J., et al. Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene. Hum Mol Genet 2010, 19:4643-4653.
40. Saxena A., Tabin C.J. miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation. Proc Natl Acad Sci U S A 2010, 107:87-91.
41. O'Brien J.E., Kibiryeva N., Zhou X.G., et al. Noncoding RNA expression in myocardium from infants with tetralogy of Fallot. Circ Cardiovasc Genet 2012, 5:279-286.
42. Chen J., Huang Z.P., Seok H., et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 2013, 112:1557-1566.
43. Huang Z.P., Chen J.F., Regan J.N., et al. Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects. Arterioscler Thromb Vasc Biol 2010, 30:2575-2586.
44. Gambardella S., Rinaldi F., Lepore S.M., et al. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. JTransl Med 2010, 8:48.
45. Zhang Z., O'Rourke J.R., McManus M.T., et al. The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning. Dev Biol 2011, 351:254-265.
46. Nishi H., Ono K., Horie T., et al. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol Cell Biol 2011, 31:744-755.
47. Wang J., Song Y., Zhang Y., et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2012, 22:516-527.
48. Blue G.M., Kirk E.P., Sholler G.F., Harvey R.P., Winlaw D.S. Congenital heart disease: current knowledge about causes and inheritance. Med J Aust 2012, 197:155-159.